Latest Breaking News On - Agepha pharma - Page 2 : comparemela.com

Top General Cardiology and CVD Prevention News of 2023

Several new drugs have appeared on the scene, and a long-familiar anti-inflammatory splashed into the cardiology space.

The Biggest News of 2023: TCTMD's Top 10

Major regulatory news and RCTs topped the list, but COVID-19 and the opioid pandemic had an impact, as did a UK TAVI furor.

TRANSFORM trial will harness AI to evaluate personalized heart disease care strategies

Inflammation predicts events more than cholesterol in high-risk statin-intolerant patients

Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation

While promising, the technology has much to prove, including how much it really adds to standard risk prediction.